A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.
申请公布号
AU2009263974(B2)
申请公布日期
2015.02.05
申请号
AU20090263974
申请日期
2009.06.25
申请人
CANCER RESEARCH TECHNOLOGY LIMITED
发明人
VALEUR, ERIC;GOLDING, BERNARD THOMAS;NOBLE, MARTIN;RIEDINGER, CHRISTIANE;HARDCASTLE, IAN ROBERT;WATSON, ANNA FRANCES;GRIFFIN, ROGER JOHN
